Literature DB >> 14606817

Synthesis of a diverse library of mechanism-based cysteine protease inhibitors.

Warren J L Wood1, Lily Huang, Jonathan A Ellman.   

Abstract

We report improvements of our method for the solid-phase synthesis of mechanism-based mercaptomethyl ketone inhibitors of cysteine proteases (Lee, A.; Huang, L.; Ellman, J. A. J. Am. Chem. Soc. 1999, 121, 9907-9914). Specifically, Fmoc-protected chloromethyl ketones were used, rather than the Alloc-protected counterparts. In addition, we further demonstrated that diverse polar functionality can be incorporated at the R1', R1, and R2 sites, in contrast to our previous efforts, where primarily hydrophobic groups were incorporated at these positions. On the basis of these results, a 2016-membered library of potential mercaptomethyl ketone inhibitors was prepared that incorporated diverse functionality. The library was screened against cathepsin B, which is implicated in cancer, resulting in the identification of single-digit nanomolar inhibitors. Because of the diverse functionality incorporated in this library, it should be a rich source of potent inhibitors against many other cysteine proteases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14606817     DOI: 10.1021/cc034008r

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  5 in total

1.  Examination of the new alpha-(2'Z-fluoro)vinyl trigger with lysine decarboxylase: the absolute stereochemistry dictates the reaction course.

Authors:  Kannan R Karukurichi; Roberto de la Salud-Bea; Wan Jin Jahng; David B Berkowitz
Journal:  J Am Chem Soc       Date:  2007-01-17       Impact factor: 15.419

2.  A road less traveled by: exploring a decade of Ellman chemistry.

Authors:  Anang A Shelat; R Kiplin Guy
Journal:  Bioorg Med Chem       Date:  2008-03-04       Impact factor: 3.641

3.  Modulation of the inhibitor properties of dipeptidyl (acyloxy)methyl ketones toward the CaaX proteases.

Authors:  Anne-Marie R Dechert; James P MacNamara; Sarah R Breevoort; Emily R Hildebrandt; Ned W Hembree; Adam C Rea; Duncan E McLain; Stephen B Porter; Walter K Schmidt; Timothy M Dore
Journal:  Bioorg Med Chem       Date:  2010-07-21       Impact factor: 3.641

4.  Loss of presenilin 2 is associated with increased iPLA2 activity and lung tumor development.

Authors:  H-M Yun; M H Park; D H Kim; Y J Ahn; K-R Park; T M Kim; N Y Yun; Y S Jung; D Y Hwang; D Y Yoon; S B Han; J T Hong
Journal:  Oncogene       Date:  2014-05-26       Impact factor: 9.867

5.  Novel inhibitors and activity-based probes targeting serine proteases.

Authors:  Timothy E G Ferguson; James A Reihill; S Lorraine Martin; Brian Walker
Journal:  Front Chem       Date:  2022-09-28       Impact factor: 5.545

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.